HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji Seon Park Selected Research

2- (3- benzoyl)- 4- hydroxy- 1,1- dioxo- 2H- 1,2- benzothiazine- 2- yl- 1- phenylethanone

8/2016Anti-inflammatory effect of a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor via the stimulation of heme oxygenase-1 in LPS-activated mice and J774.1 murine macrophages.
4/2011Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji Seon Park Research Topics

Disease

6Type 2 Diabetes Mellitus (MODY)
12/2015 - 03/2011
5Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2015 - 04/2011
4Obesity
12/2015 - 04/2011
4Insulin Resistance
04/2014 - 09/2012
3Infections
08/2020 - 08/2010
2Inflammation (Inflammations)
08/2016 - 12/2013
2Body Weight (Weight, Body)
12/2013 - 09/2012
1Arthritis (Polyarthritis)
08/2020
1Infectious Arthritis (Septic Arthritis)
08/2020
1Amyloidosis
06/2016
1Spontaneous Fractures (Pathological Fracture)
06/2016
1Joint Diseases (Joint Disease)
06/2016
1Multiple Myeloma
06/2016
1Arthralgia (Joint Pain)
06/2016
1Osteomyelitis
01/2016
1Pain (Aches)
11/2014
1Osteoporosis
04/2014
1Fatty Liver
09/2012
1Hypertension (High Blood Pressure)
09/2012
1Abdominal Obesity
09/2012
1Cushing Syndrome
09/2012
1Diabetes Mellitus
09/2012
1Glucose Intolerance
04/2011
1Femoracetabular Impingement
02/2011
1Abscess
08/2010
1Tendinopathy (Tendonitis)
08/2010
1Hyperplasia
03/2007
1Hemorrhage
03/2007
1Pathologic Constriction (Stenosis)
03/2007
1Portal Hypertension
03/2007
1Osteolysis
11/2004
1Tuberculosis (Tuberculoses)
04/2004
1Focal Nodular Hyperplasia
01/2003
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
02/2002

Drug/Important Bio-Agent (IBA)

5Oxidoreductases (Dehydrogenase)IBA
12/2015 - 04/2011
5Glucose (Dextrose)FDA LinkGeneric
04/2014 - 04/2011
22- (3- benzoyl)- 4- hydroxy- 1,1- dioxo- 2H- 1,2- benzothiazine- 2- yl- 1- phenylethanoneIBA
08/2016 - 04/2011
2CorticosteroneIBA
12/2013 - 09/2012
1Amyloid (Amyloid Fibrils)IBA
06/2016
1ScleroproteinsIBA
06/2016
1Amyloidogenic ProteinsIBA
06/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1tanshinoneIBA
12/2015
1P-30 composite resin (P 30)IBA
05/2015
1Polyethylene (Polythene)IBA
11/2014
1N- (5- carbamoyladamantan- 2- yl)- 3- ((2- fluorophenyl)sulfonyl)thiazolidine- 2- carboxamideIBA
12/2013
1Insulin (Novolin)FDA Link
12/2013
1ElementsIBA
09/2012
1GlucocorticoidsIBA
09/2012
14- (2- (1,1- dioxido- 6- (2,4,6- trichlorophenyl)- 1,2,6- thiadiazinan- 2- yl)acetamido)adamantane- 1- carboxamideIBA
09/2012
1SterolsIBA
09/2012
1CytokinesIBA
09/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2012
1CarbenoxoloneIBA
09/2012
1LeptinIBA
03/2011
1Rosiglitazone (Avandia)FDA Link
03/2011
1Indicators and Reagents (Reagents)IBA
02/2011
1Durapatite (Hydroxylapatite)IBA
08/2010
1Ethiodized Oil (Ethiodol)FDA Link
03/2007
1Holmium-166IBA
03/2007
1EnbucrilateIBA
03/2007
1ParaffinIBA
04/2004
1Formaldehyde (Formol)FDA Link
04/2004
1Capsules (Microcapsules)IBA
01/2003
1TubulinIBA
02/2002
1Docetaxel (Taxotere)FDA Link
02/2002
1Glutathione S-Transferase piIBA
02/2002

Therapy/Procedure

3Hip Replacement Arthroplasty (Total Hip Replacement)
06/2016 - 11/2004
2Therapeutics
01/2016 - 04/2004
1Debridement
08/2020
1Surgical Portasystemic Shunt (Portosystemic Shunt)
03/2007
1Transjugular Intrahepatic Portasystemic Shunt
03/2007
1Reoperation
11/2004